175 related articles for article (PubMed ID: 17895403)
1. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
Jones S; Tucker KL; Sage T; Kaiser WJ; Barrett NE; Lowry PJ; Zimmer A; Hunt SP; Emerson M; Gibbins JM
Blood; 2008 Jan; 111(2):605-12. PubMed ID: 17895403
[TBL] [Abstract][Full Text] [Related]
2. Tachykinins regulate the function of platelets.
Graham GJ; Stevens JM; Page NM; Grant AD; Brain SD; Lowry PJ; Gibbins JM
Blood; 2004 Aug; 104(4):1058-65. PubMed ID: 15130944
[TBL] [Abstract][Full Text] [Related]
3. Tweaking the gain on platelet regulation: the tachykinin connection.
Gibbins JM
Atherosclerosis; 2009 Sep; 206(1):1-7. PubMed ID: 19150714
[TBL] [Abstract][Full Text] [Related]
4. The neurokinin 1 receptor: a potential new target for anti-platelet therapy?
Jones S; Gibbins JM
Curr Opin Pharmacol; 2008 Apr; 8(2):114-9. PubMed ID: 18296119
[TBL] [Abstract][Full Text] [Related]
5. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
[TBL] [Abstract][Full Text] [Related]
6. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
Wang LL; Han Y; Guo Z; Han SQ; Liu T
Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276
[TBL] [Abstract][Full Text] [Related]
7. Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium.
Stumm R; Culmsee C; Schafer MK; Krieglstein J; Weihe E
J Neurosci; 2001 Feb; 21(3):798-811. PubMed ID: 11157066
[TBL] [Abstract][Full Text] [Related]
8. Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor.
Nederpelt I; Bleeker D; Tuijt B; IJzerman AP; Heitman LH
Biochem Pharmacol; 2016 Oct; 118():88-95. PubMed ID: 27501920
[TBL] [Abstract][Full Text] [Related]
9. Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation.
Helyes Z; Elekes K; Sándor K; Szitter I; Kereskai L; Pintér E; Kemény A; Szolcsányi J; McLaughlin L; Vasiliou S; Kipar A; Zimmer A; Hunt SP; Stewart JP; Quinn JP
Neuropeptides; 2010 Oct; 44(5):399-406. PubMed ID: 20579732
[TBL] [Abstract][Full Text] [Related]
10. Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P.
Wijkhuisen A; Sagot MA; Frobert Y; Créminon C; Grassi J; Boquet D; Couraud JY
FEBS Lett; 1999 Mar; 447(2-3):155-9. PubMed ID: 10214937
[TBL] [Abstract][Full Text] [Related]
11. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
[TBL] [Abstract][Full Text] [Related]
12. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist.
Cascieri MA; Ber E; Fong TM; Hale JJ; Tang F; Shiao LL; Mills SG; MacCoss M; Sadowski S; Tota MR; Strader CD
Eur J Pharmacol; 1997 May; 325(2-3):253-61. PubMed ID: 9163573
[TBL] [Abstract][Full Text] [Related]
14. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
[TBL] [Abstract][Full Text] [Related]
15. Circadian nuclear receptor Rev-erbα is expressed by platelets and potentiates platelet activation and thrombus formation.
Shi J; Tong R; Zhou M; Gao Y; Zhao Y; Chen Y; Liu W; Li G; Lu D; Meng G; Hu L; Yuan A; Lu X; Pu J
Eur Heart J; 2022 Jun; 43(24):2317-2334. PubMed ID: 35267019
[TBL] [Abstract][Full Text] [Related]
16. The NK1 receptor is involved in the neurokinin-induced shape change of rabbit platelets.
Savi P; Laplace MC; Le Fur G; Emonds-Alt X; Herbert JM
FEBS Lett; 1992 Nov; 312(2-3):200-2. PubMed ID: 1385216
[TBL] [Abstract][Full Text] [Related]
17. Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
Zhang Y; Zhang J; Yan R; Tian J; Zhang Y; Zhang J; Chen M; Cui Q; Zhao L; Hu R; Jiang M; Li Z; Ruan C; He S; Dai K
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2964-2969. PubMed ID: 28242694
[TBL] [Abstract][Full Text] [Related]
18. Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms.
Hunyady Á; Hajna Z; Gubányi T; Scheich B; Kemény Á; Gaszner B; Borbély É; Helyes Z
Brain Res Bull; 2019 Apr; 147():165-173. PubMed ID: 30664920
[TBL] [Abstract][Full Text] [Related]
19. In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
van Gestel MA; Heemskerk JW; Slaaf DW; Heijnen VV; Reneman RS; oude Egbrink MG
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):518-23. PubMed ID: 12615691
[TBL] [Abstract][Full Text] [Related]
20. Non-neuronal mammalian tachykinin expression.
Nelson DA; Bost KL
Front Biosci; 2004 Sep; 9():2166-76. PubMed ID: 15353278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
